Oscar Health (OSCR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, to be held virtually, with voting available online, by phone, or mail.
Key business includes election of eight directors, advisory vote on executive compensation, and ratification of PWC as auditor.
Company highlights include record membership growth to 3.4 million, 28% revenue increase to $11.7B, and significant SG&A ratio improvement.
Strategic leadership changes and compensation program updates reflect a focus on long-term growth and shareholder alignment.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eight directors, (2) advisory say-on-pay for executive compensation, (3) ratification of PWC as independent auditor.
Board recommends voting FOR all proposals.
Shareholders may submit additional proposals for future meetings per bylaw requirements.
Board of directors and corporate governance
Board consists of eight nominees with diverse backgrounds in healthcare, technology, finance, and public policy.
Majority of directors and all committees are independent; Mr. Sankaran to become independent Chair after the meeting.
Active board refreshment with three new directors in five years; robust annual board and committee evaluations.
Stockholder engagement led to changes in committee composition and incentive metrics.
Comprehensive director orientation and ongoing education programs in place.
Latest events from Oscar Health
- Votes will be cast on directors, executive pay, and auditor ratification at the June 2026 meeting.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Record 2025 revenue and membership, but higher costs led to a net loss; 2026 targets profitability.OSCR
Q4 202510 Feb 2026 - AI, personalization, and expanded financial tools are key to driving real healthcare consumerism.OSCR
7th Annual Healthcare Symposium3 Feb 2026 - Q2 revenue up 46%, net income $56.2M, membership up 63%, and full-year guidance raised.OSCR
Q2 20242 Feb 2026 - Aims for 20% revenue CAGR and 5% margin by 2027, leveraging ACA, ICHRA, and technology.OSCR
Investor Day 20241 Feb 2026 - Reaffirmed guidance, robust growth outlook, and disciplined strategy set the stage for 2025.OSCR
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Strong growth, disciplined expansion, and AI-driven efficiency position for long-term outperformance.OSCR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - SEP-driven growth and disciplined pricing set up strong 2025 performance and long-term margin gains.OSCR
The Baird 2024 Global Healthcare Conference20 Jan 2026